Virtual Reality and Social Cognition After Acquired Brain Injury

NCT05309005 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-11-10

No results posted yet for this study

Summary

The study aim is to improve assessment and understanding of social cognitive impairment after acquired brain injury by developing and validating a virtual reality version of The Awareness of Social Inference Test (TASIT). It is expected that the VR version of the test has comparable or better psychometric properties than the video version, and that it has improved relevance to everyday social skills. It is also expected that the VR version taxes cognitive functions more than a desktop version with identical content as the VR version.

Conditions

  • TBI
  • Stroke
  • Acquired Brain Injury
  • Brain Injuries

Interventions

BEHAVIORAL

VR TASIT

Consists of a Norwegian adaptation of the 59 videos of social scenes that constitute the A Form in the original TASIT. The stimulus material in the Virtual Reality version is perceived through a head mounted display. This allows the test person to watch the scenes in three dimensions and a 360 degree angle, increasing the sense of social presence.

BEHAVIORAL

DT TASIT

Consists of a Norwegian adaptation of the 59 videos of social scenes that constitute the A Form in the original TASIT, with identical content as the VR TASIT. The stimulus material in the desktop version is perceived on a two dimensional desktop computer screen.

Sponsors & Collaborators

  • Norwegian University of Science and Technology

    collaborator OTHER
  • Sunnaas Rehabilitation Hospital

    lead OTHER

Principal Investigators

  • Marianne Løvstad, Professor · Sunnaas Rehabilitation Hospital and University of Oslo

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-15
Primary Completion
2023-12-31
Completion
2024-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05309005 on ClinicalTrials.gov